Introduction
The combination of thin-layer chromatography (TLC) and mass spectrometry (MS) is commonly used because of its different benefits. Even more important than the aspect of moderate cost is the fact that TLC plates can act as a storage system if the separation of substances and their characterization via MS has to be performed at different locations, which is quite often the case in forensic medicine. This high degree of flexibility is not offered by any other method concerning coupled systems (e.g., GC-MS).
The screening of biological samples in forensic chemistry or toxicology is performed in two main areas: the first is the detection of known compounds and the second is the detection of unknown compounds.
The detection of known compounds is a rather routine procedure. It can be done by proven methods and by the use of the corresponding compilation of analytical data for each technique (1) (2) (3) (4) .
The identification of unknown substances is somewhat difficult, but the more interesting part of toxicological research, and the identification, can be successfully achieved by TLC-MS (5) .
The role of TLC as a simple low cost method is still of importance. Furthermore this method enables the simultaneous handling of several samples. TLC negative samples do not need further analysis and, in consequence, the number of analytical procedures can be dramatically reduced. In this way, subsequent spectroscopy is only required for positive fractions.
GC-MS is normally used as a confirmation technique (6) . This often requires complex sample preparations like extraction and derivatization, which are followed by time consuming GC runs. This study describes the usefulness of off-line coupled TLC-MS as a confirmation technique for direct insertion probe EI-MS of pesticides after TLC separation.
There are other ionization methods (such as FAB-MS) described and there are also methods combined with TLC that have been reviewed by Wilson (7) that are especially useful for the detection of thermally labile compounds or for compounds with high polarity. Eight-peak mass spectrum  hRF in mobile phase  compound  Elemental  No  a  b  c  d  e  f  g  h  M +˙1  2  3  name  composition   1  43  86  234  236  128  110  70  152  269  85  88  87  Diallat  C10H17NOCl2S  2  43  86  268  128  270  143  145  147  303  69  89  90  Triallat  C10H16NOCl3S  3 C6H15O3PS2  20  88 274  186  276  60  61  97  125  274  89  93  93  Disulfoton  C8H19O2PS3  21  97 197  199  314  258  286  349  125  349  87  96  80  Chlorpyrifos  C9H11NO3Cl3PS  22  109 169  125  76  47  45  59  105  246  70  00  73  Demethon-S-methylsulfoxid C6H15O4PS2  23  109 149  99  81  139  247  275  219  275  77  22  85  Paraoxon  C10H14NO6P  24  109 125  263  79  47  6 3 93  200  263  82  40  85  Parathionmethyl  C8H10NO5PS  25  109 185  145  220  79  187  222  147  220  80  19  82  Dichlorvos  C4H7O4Cl2P  26  110 152  43  58  64  81  137  153  209  86  27  88  Propoxur  C11H15NO3  27  112 197  58  182  43  44  155  69  197  96  00  12  Hydroxiatrazin  C8H15N5O  28  123  77  167  224  226  44  91  332  332  86  20  93  Dichlofluanid  C9H11N2O2Cl2S2F  29  125 127  165  167  196  197  137  139  232  89  79  93  Chlorphenpropmethyl  C10H10O2Cl2  30  125 287  285  79  109  93  97  167  320  96  75  93  Fenchlorphos  C8H8O3Cl3PS  31  127  67  193  237  44  109  72  111  237  76  11  66  Dicrotophos  C8H16O5NP  32  127 192  109  224  43  67  164  95  224  80  06  85  Mevinphos  C7H13O6P  33  132  77  160  104  97  65  129  51  345  80  16  85  Azinphos-ethyl  C12H16N3O3PS2  34  137 227  155  121  109  77  94  157  344  85  80  75  Methoxychlor  C16H15O2Cl3  35  139 141  251  253  111  113  141  75  368  89  80  91  Dicofol  C14H9OCl5  36  142 157  200  114  144  159  202  116  200  76  00  33  Metoxuron-didesmethyl  C8H9N2O2Cl  37  142 157  214  114  144  159  216  116  214  79  00  51  Metoxuron-monodesmethyl C9H11N2O2Cl  38  142 107  77  214  169  89  144  216  214  96  00  13  Mecoprop  C10H11O3Cl  39  143  87  43  235  115  77  132  218  235  85  38  90  Carboxin  C12H13NO2S  40  144 115  116  201  127  136  89  71  201  58  06  68  Carbaryl  C12H11O2N  41  151 126  166  223  51  58  108  79  223  86  14  88  Bendiocarb  C11H13NO4  42  153  43  53  69  81  82  110  136  234  82  10  81  Lenacil  C13H18N2O2  43  156  93  281  125  43  55  63  68  281  78  02  32  Menazon  C6H12N5O2PS2  44  156 110  58  79  126  47  95  141  213  65  10  52  Omethoat  C5H12NO4PS  45  159 191  43  105  88  132  146  119  290  76  03  92  Benomyl  C14H18N4O3  46  160 135  44  294  77  92  104  251  294  89  06  72  Triamiphos  C12H19N6OP  47  160 132  77  93  104  125  147  172  317  80  15  85  Azinphos-methyl  C10H12N3O3PS2  48  164 136  135  221  96  163  108  69  221  83  10  87  Methabenzthiazuron  C10H11N3OS  49  169 109  125  142  79  47  127  93  262  74  00  76  Demethon-S-methylsulfon C6H15O5PS2  50  170 134  199  243  172  198  245  108  243  80  00  06  Benazolin  C9H6O3NClS  51  171 173  100  75  136  50  61  109  171  96  80  92  Dichlobenil  C7H3NCl2  52  173 175  220  222  203  191  97  109  220  90  00  06  Dicamba  C8H6O3Cl2  53  173 174  146  230  105  57  77  89  230  89  00  85  Pivalylindandion  C14H14O3  54  185 226  241  170  157  43  68  71  241  77  06  70  Terbutyne  C10H19N5S  55  191 159  105  119  146  132  78  90  191  82  07  60  Carbendazim  C9H9N3O2  56  196 198  268  270  200  223  225  272  268  85  00  09 Fenoprop C9H7O3Cl3 57  198  42  57  61  104  145  214  183  214  85  38  87  Metribuzin  C8H14N4OS  58  200 215  58  173  68  122  132  138  215  77  04  70  Atrazin  C8H14N5Cl  59  205 207  231  233  188  190  260  262  260  80  00  80  Bromacil  C9H13N2O2Br  60  211 163  147  117  240  77  65  89  240  92  00  91  Dinoseb  C10H12N2O5  61  213 198  171  58  57  82  99  124  213  73  04  68  Desmetryne  C8H15N5S  62  214 229  172  187  58  99  43  152  229  75  05  72  Propazine  C9H16N5Cl  63  221  97  232  373  237  265  65  91  373  87  67 C19H15O4Cl  75  306 264  335  43  248  290  316  318  335  85  80  88  Trifluralin  C13H16N3O4F3  76  316 274  300  345  258  43  328  216  345  85  24  90  Nitralin  C13H19N3O6S  77  322 202  97  266  238  294  65  121  322  96  86  93  Sulfotep  C8H20O5P2S2  78  331 329  333  125  109  314  316  213  364  81  80  87  Bromophos-methyl  C8H8O3Cl2BrPS  79  359 357  361  303  331  97  242  213  392  81  80  87  Bromophos-ethyl  C10H12O3Cl2BrPS  80  43  58  68  255  113  152  184  240  255  35  35  95  Dipropetryn  C11H21N5S  81  43 128  86  189  132  41  89  75  189  69  63  97  EPTC  C9H19NOS  82  43 161  207  79  137  133  105  286  286  25  50  95  Ethofumesate  C13H18O5S  83  43  93  179  137  120  65  41  77  179  39  57  94  Propham  C10H13NO2  84  51 121  53  52  50  77  105  198  198  06  38  45  DNOC  C7H6N2O5  85  53 110  236  68  127  164  179  207  236  20  29  93  Buturon  C12H13ClN2O  86  57 127  41  43  55  88  243  42  371  04  19  39  Ioxynil  C7H3J2NO  87  57 231  103  125  153  186  203  41  288  63  90  99  Terbufos  C9H21O2PS3  88  57 208  85  181  110  128  293  236  293  22  23  94  Triadimefon  C14H16ClN3O2  89  61  46  294  206  292  60  45  63  292  22  30  92  Chlorbromuron  C9H10ClBrN2O2  90  66 263  293  79  91  101  329  364  362  89  98  99  Aldrin  C12H8Cl6  91  72  89  127  198  45  99  141  154  198  13  05  79  Cycluron  C11H22N2O  92  72 241  286  77  90  92  226  63  286  08  05  83  Difenoxuron  C16H18N2O3  93  72 164  44  65  42  77  91  51  164  11  07  81  Fenuron  C9H12N2O  94  72 232  44  213  187  145  113  95  232  16  09  87  Fluometuron  C10H11F3N2O  95  72 198  44  200  73  42  99  100  198  13  07  83  Monuron  C9H11ON2Cl  96  72 166  238  167  42  44  138  109  238  26  17  92  Pirimicarb  C11H18N4O2  97  77  97  129  157  125  141  103  298  298  42  86  97  Phoxim  C12H15N2O3PS  98  79 108  263  345  380  237  277  279  378  65  87  99  Dieldrin  C12H8OCl6  99  79 109  110  139  145  80  112  95  256  04  02  62  Trichlorfon  C4H8Cl3O4P  100  81 263  281  279  261  265  79  82  378  71  90  99  Endrin  C12H8OCl6  101  84  57  43  42  85  69  54  41  84  00  00  06  Amitrol  C2H4N4  102  88  62  61  53  277  63  89  87  275  8  16  40  Bromoxynil  C7H3Br2NO  103  88  44  120  240  77  55  56  76  240  19  51  94  Thiram  C6H12N2S4  104  94  95  141  64  47  46  79  80  141  01  00  37  Methamidophos  C2H8NO2PS  105  97 121  65  47  154  93  125  234  234  64  91  99  Chlormephos  C5H12ClO2PS2  106  109 125  79  297  128  47  63  93  297  31  71  97  Chlorthion  C8H9ClNO5PS  107  109 137  246  110  81  63  65  77  246  59  89  97  Fonofos  C10H15OPS2  108  109 137  246  290  110  305  276  69  305  49  75  100  Pirimiphos-methyl  C11H20N3O3PS  109  115  57  83  41  172  143  161  218  218  20  17  94  Thiofanox  C9H18N2O2S  110  123 136  107  79  93  91  81  67  302  48  52  97  Bioallethrin  C19H26O3  111  125 173  127  93  99  158  143  285  330  31  53  96  Malathion  C10H19O6PS2  112  125  93  109  79  46  203  63  171  466  23  75  98  Temephos  C16H20O6P2S3 trolled heating at 200 o C. EI spectra were obtained at 100 eV of ionization energy in full-scan mode. The eight peak mass spectra are tabulated in Table I .
Preparation of biological samples
The TLC plates were pretreated with a solution of methanol-1.5% aqueous ammonia (25%), reactivated for 2 h at 150 o C in a clean heating oven, and subsequently cooled in a clean closed system .The samples to be determined were obtained from stomach content by liquid-liquid extraction at a neutral pH or by solid-phase extraction (SPE). SPE was performed using 1 mL liquid stomach content diluted with 4 mL of phosphate buffer (pH 6) and vortex mixed for 1 min. The buffered matrix was centrifuged and the supernatant was used for separation on Bond Elute columns (9) . The extracts derived from liquid-liquid extraction of fatty samples were further cleaned by liquid-liquid extraction using acetonitrile-petroleum (light fraction) (10) .
The extracts were applied to the TLC plate as spots. This method allowed the development of ten extracts simultaneously. If any unknown compounds were detected, the extracts containing these compounds were applied to a pretreated plate as a band and subsequently developed with an appropriate mobile phase. One part of the TLC plate (~ 2 cm) was used for detection of the substances by use of color reactions. One or more bands to be investigated by MS were marked, scratched from the plate, extracted with methanol-dichloromethane (1:1, v/v) under sonication for 5 min, and centrifuged. The supernatant was transferred to another clean tube and evaporated to dryness by means of a gentle stream of nitrogen. The residue was dissolved in methanol (20 mL) and this solution (5 mL) was transferred to a quartz MS crucible and the solvent was evaporated again. The dry sample was transferred to the MS (5).
Results and Discussion
The hR f data of 151 pesticides are listed in Table I in addition to eight peak mass spectra under EI. The plot of solvent systems against each other (S1/S2, S1/S3, S2/S3) (Figure 1 ) confirms the ability of these systems to determine many pesticides. The same results are obtained with solvent systems S4-S6. In addition to EI-MS, the plot of base peak against the hRf shows that with this additional tool a more satisfying identification is achieved ( Figure  1 , plot EI against S1). The other solvent systems show comparable results.
Conclusion
In conclusion, these results show that TLC-MS in any kind of ionization procedure is a valuable method. It can be applied to a very wide range of analytes (5, 7) and is comparable to HPLC-based methods. Because of off-line coupling, TLC-MS can even be applied to analytes that are unsuitable for other separation techniques.
This screening technique can be used in practice as an alternative to GC-MS. The most important advantage is the possibility of quick analyses in the case of intoxications in emergency medicine.
